PCDH17, protocadherin 17, 27253

N. diseases: 51; N. variants: 5
Disease: Carcinoma of bladder ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder 		0.050 AlteredExpression disease BEFREE The p53 mutation, the expression of p53 and PCDH17 were significantly associated with survival from bladder cancer. 31772653 2019
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder 		0.050 Biomarker disease BEFREE The combination of POU4F2/PCDH17 has yielded the highest sensitivity and specificity of 90.00% and 93.96% in all the 312 individuals, showing the capability of detecting BlCa effectively among pathologically varied sample groups. 26700620 2016
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder 		0.050 PosttranslationalModification disease BEFREE PCDH17 promoter methylation is closely associated with bladder cancer malignancy and may be used as an independent predictor of clinical outcomes in patients with bladder cancer. 24567353 2014
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder 		0.050 PosttranslationalModification disease BEFREE PCDH17 promoter methylation was significantly associated with malignant behaviour and poor prognosis of bladder cancer. 24366498 2014
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder 		0.050 PosttranslationalModification disease BEFREE PCDH17 and TCF21 methylation levels provided a sensitivity rate of 92% for bladder cancer, 67% for renal cell tumors and 96% for prostate cancer. 21847011 2011